Flavonoid Scaffolds as Promising Antiviral Leads Against Varicella Zoster Virus (Chickenpox): A Structure-Guided Virtual Screening Study
DOI:
https://doi.org/10.26538/tjdr/v3i1.2Keywords:
Varicella-Zoster Virus, Flavonoids, Molecular Docking, MM-GBSA, Molecular Dynamics, ADMETAbstract
Purpose: Varicella-Zoster Virus (VZV) remains a significant global health concern, particularly among immunocompromised and vulnerable populations. Limitations associated with existing antiviral therapies, including adverse effects and emerging resistance, necessitate the identification of safer and more effective alternatives. This study employed a structure-guided in-silico strategy to identify flavonoid-based inhibitors targeting VZV thymidine kinase (VZV-TK).
Methods: A curated library of 264 flavonoids was subjected to hierarchical molecular docking using the Schrödinger suite, followed by binding free energy estimation via the MM-GBSA approach. Pharmacokinetic and toxicity properties were evaluated through ADMET profiling. The most promising ligand–protein complexes were further assessed using 100 ns all-atom molecular dynamics simulations to examine binding stability and conformational behavior.
Results: Several flavonoids demonstrated strong binding affinity toward VZV-TK. Neohesperidin dihydrochalcone exhibited the most favorable binding free energy, indicating high thermodynamic stability, while naringin dihydrochalcone and myricitrin showed docking scores comparable to the co-crystallized reference ligand. Molecular dynamics analyses identified myricitrin as the most dynamically stable inhibitor, characterized by low backbone RMSD, persistent hydrogen-bonding interactions, and preserved protein compactness. ADMET predictions indicated acceptable physicochemical properties and low carcinogenicity risk for the lead compounds.
Conclusion: The integrated computational analyses highlight flavonoid scaffolds, particularly myricitrin, neohesperidin dihydrochalcone, and naringin dihydrochalcone, as promising VZV-TK inhibitors. These findings provide a strong rationale for further experimental validation and support the development of plant-derived antivirals for Varicella-Zoster Virus infection.
Downloads
References
1. Tommasi C, Breuer J. The Biology of Varicella-Zoster Virus Replication in the Skin. Viruses. 2022;14(5):982.
2. Shah HA, Meiwald A, Perera C, Casabona G, Richmond P, Jamet N. Global Prevalence of Varicella-Associated Complications: A Systematic Review and Meta-Analysis. Infectious Diseases and Therapy. 2023;13(1):79–103.
3. Grose C. Surveillance of Nigerian children suggests that varicella may be a risk factor for acquisition of monkeypox. Frontiers in Public Health. 2023;11.
4. Ishihara R, Watanabe R, Shiomi M, Katsushima M, Fukumoto K, Yamada S, Okano T, Hashimoto M. Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine. Biomolecules. 2024;14(7):739.
5. Papaevangelou V, Quinlivan M, Lockwood J, Papaloukas O, Sideri G, Critselis E, Papassotiriou I, Papadatos J, Breuer J. Subclinical Varicella-Zoster Virus reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration. Clinical Microbiology and Infection.2013;19(5):E245–E251.
6. Tayyar R, HoD. Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients. Viruses. 2023;15(2):439.
7. AhmadF, SachdevaA, SahB. K, Kumar A, Kumar R, Seksaria B. A review of herbal therapeutics for the prevention and management of poxvirus infections. Archives of Microbiology.2025;207(8).
8. Sharma S, Ghosh P, Kar C, Ghosh R. Anticipating Viral Challenges: A Perspective on Phytochemicals against Existing and Emerging Viruses. Anti-Infective Agents. 2025;23(3).
9. Outbreak of chickenpox at Benue’s IDP camp. Daily Post Nigeria. (2023, August 28). Available from: https://dailypost.ng/2023/08/28/outbreak-of-chickenpox-at-benues-idp-camp/
10. Olumade T. J, Adesanya O. A, Fred-Akintunwa IJ, Babalola DO, Oguzie JU, Ogunsanya OA, George UE, Akin-Ajani OD, Osasona DG. Infectious disease outbreak preparedness and response in Nigeria: history, limitations and recommendations for global health policy and practice. AIMS Public Health. 2020;7(4):736–757.
11. Omoboyowa DA, Kareem JA, Saibu OA, Bodun DS, Ajayi TM, Oyeneyin OE. Identification of phyto-compounds from Ilex kudingcha as inhibitors of sterol-14α demethylase protease: A computational approach against Chagas disease. Chemistry Africa.2022;6(3):1335–1347.
12. Bodun DS, Omoboyowa DA, Omotuyi OI, Olabisi AO, Oyinloye BE, Abioye AE, Adegboyega AE, Akindele OO, Irekeola AA, Agunu A. QSAR-based virtual screening of traditional Chinese medicine for the identification of mitotic kinesin Eg5 inhibitors. Computational Biology and Chemistry.2023;104: 107865.
13. Duru CE, and Chidiebere CW. Computer-assisted discovery of tyrosinase inhibitors from turmeric and clove: an in silico study on natural skin whitening agents and their potential toxicity. South African Journal of Botany. 2024;175:669-683.
14. Nwofor OK, Duru CE, Nwofor CN. In-vitro, bioinformatics, and computational biophysical analyses of antifungal phytochemicals from Acalypha wilkisiana variants targeting Malassezia lipase. Trop J Drug Res. 2025;2(9):231–244.
15. Chidiebere CW, Duru CE, Mbagwu JPC. Application of computational chemistry in chemical reactivity: A review. J Niger Soc Phys Sci. 2021; 3:292–297.
16. Ikezu UM, Duru CE, Ikpa CB, Ibe FC. In silico discovery of dual-targeting molecules from Acalypha wilkesiana against hypertension and hyperglycemia. Discover Chemistry. 2025;2(1).
17. Durrant JD, McCammon JA. Molecular dynamics simulations and drug discovery. BMC Biology. 2011;9(1):71.
18. Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods:II. The accuracy of binding free energy calculations based on molecular dynamics simulations. Journal of Chemical Information and Modeling. 2010;32(5):866–877.
19. Forouzesh N, Mishra N. An effective MM/GBSA protocol for absolute binding free energy calculations: A case study on SARS-CoV-2 spike protein and the human ACE2 receptor. Molecules. 2021;26(8):2383.
20. Duru IA, Enenebeaku UE, Ngozi-Olehi LC, Enyoh CE, Duru CE, Umar HI, Kuthi NA, Kurma N, Dharmarpu V. Experimental and computational insights into Gangronema latifolium leaf compounds as GLP-1 receptor agonists. Chemistry Africa. 2024;7(5), 2581–2597.
21. Duru CE, Izuagba FO, Duru IA, Nwakile TI, Nwadike CD. Computational structure-based identification of silymarin as a promising flavonoid inhibitor of the diphtheria toxin catalytic domain. Discover Chem. 2025;2:286.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
